- Home
- XLO vs CMBM Comparison
XLO vs CMBM Comparison
Compare XLO & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XLO | CMBM |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.4M | 33.6M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | XLO | CMBM |
|---|---|---|
| Price | $0.53 | $1.16 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 437.3K | 129.0K |
| Earning Date | 04-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,344,000.00 | ★ $220,195,000.00 |
| Revenue This Year | $626.78 | N/A |
| Revenue Next Year | $79.08 | $18.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $0.23 |
| 52 Week High | $1.18 | $6.80 |
Technical Indicators
Market Signals| Indicator | XLO | CMBM |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 39.77 |
| Support Level | $0.50 | $1.13 |
| Resistance Level | $0.74 | $1.81 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 23.44 | 30.77 |
Price Performance
Historical ComparisonAbout XLO Xilio Therapeutics Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.